首页> 外文期刊>Virology >To hit or not to hit: Large-scale sequence analysis and structure characterization of influenza A NS1 unlocks new antiviral target potential
【24h】

To hit or not to hit: Large-scale sequence analysis and structure characterization of influenza A NS1 unlocks new antiviral target potential

机译:击中或不击中:流感的大规模序列分析和结构表征NS1解锁了新的抗病毒目标潜力

获取原文
获取原文并翻译 | 示例
           

摘要

Influenza NS1 protein is among the most promising novel druggable anti-influenza target, based on its structure; multiple interactions; and global function in influenza replication and pathogenesis. Notwithstanding, drug development guidance based on NS1 structural biology is lacking. Here, we design a promising strategy directed to highly conserved druggable regions as a result of an exhaustive large-scale sequence analysis and structure characterization of NS1 protein across human-infecting influenza A subtypes, over the past 100 years. We have identified 3 druggable pockets and 8 new potential hot spot residues in the NS1 protein, not described before, additionally to other 16 sites previously identified, which represent attractive targets for pharmacological modulation. This study provides a rationale towards structure-function studies of NS1 druggable sites, which have the potential to accelerate the NS1 target validation. This research also contributes to a deeper comprehension and insight into the evolutionary dynamics of influenza A NS1 protein.
机译:流感NS1蛋白是基于其结构的最有前途的新型可毒性抗流感靶标。多次互动;和流感复制和发病机制的全局功能。尽管如此,缺乏基于NS1结构生物学的药物开发指导。在这里,我们设计了一个有希望的策略,该策略是由于在过去的100年里,由于人类传染性流感的NS1蛋白的详尽的大规模序列分析和结构表征是NS1蛋白的粗糙大规模序列分析和结构表征。我们在NS1蛋白中鉴定了3种可药物袋和8个新的潜在的热点残留物,此外,另外于先前鉴定的其他16位点,这代表了药理学调制的有吸引力的靶标。本研究提供了对NS1可药位点的结构功能研究的理由,具有加速NS1目标验证的可能性。该研究还有助于更深入地理解和洞察流感NS1蛋白的进化动态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号